Yazar "Zoghi, M." seçeneğine göre listele
Listeleniyor 1 - 20 / 46
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Apical hypertrophic cardiomyopathy can mimic ischemic, heart diseases(Elsevier Science Bv, 2007) Duygu, H.; Zoghi, M.; Nalbantgil, S.; Ozerkan, F.; Akilli, A.; Akin, M.Öğe Assessment of Right Ventricular Systolic Function in Heart Transplant Patients: Correlation between Echocardiography and Cardiac Magnetic Resonance Imaging. Investigation of the Accuracy and Reliability of Echocardiography(Elsevier Science Inc, 2013) Simsek, E.; Nalbantgil, S.; Ceylan, N.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe Atrial fibrillation and heart failure: double trouble for hospitalized patients with acute decompensated heart failure(Wiley, 2018) Kocabas, U.; Sinan, U. Y.; Arugaslan, E.; Kursun, M.; Coner, A.; Celebi, O. Ozcan; Ozturk, C.; Dalgic, O.; Turkoglu, I.; Kemal, H. S.; Gazi, E.; Altin, C.; Zoghi, M.Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe CHA2DS2-Vasc and HAS-BLED Scores as Predictors of Ischemic and Hemorrhagic Stroke Risk After Left Ventricular Assist Device Implantation(Elsevier Science Inc, 2015) Kemal, H. S.; Ertugay, S.; Nalbantgil, S.; Zoghi, M.; Engin, C.; Yagdi, T.; Ozbaran, M.Öğe A circadian rhythm of syncope in patients with vasovagal syncope(Oxford Univ Press, 2006) Zoghi, M.; Duygu, H.; Nalbantgil, S.; Yavuzgil, O.; Akin, M.; Payzin, S.; Akilli, A.Öğe Clinical characteristics and in-hospital outcomes of HF with mid-range versus preserved and reduced ejection fraction: a subgroup analysis from Journey HF-TR study(Wiley, 2017) Zoghi, M.; Sinan, U. Y. Umit Yasar; Gurbuz, D. C.; Celik, O.; Cakmak, H. A.; Kilic, S.; Inci, S.; Gok, G.; Kucukoglu, M. S.Öğe Clinical outcomes in patients with ischemic versus non-ischemic cardiomyopathy after angiotensin-neprilysin inhibition therapy(Wiley, 2023) Sabanoglu, C. Cengiz; Inanc, I. H.; Ekici, B.; Zoghi, M.[No abstract available]Öğe Comparison of Heart Transplantation Patients with Ischemic and Idiopathic Dilated Cardiomyopathy(Elsevier Science Inc, 2011) Gungor, H.; Oguz, E.; Ayik, M. F.; Ertugay, S.; Engin, C.; Yagdi, T.; Nalbantgil, S.; Zoghi, M.; Ozbaran, M.Objective. We retrospectively analyzed our data to compare preoperative demographic, laboratory, echocardiographic, hemodynamic findings mortality and survival rates of heart transplantation patients with ischemic (ICM) and idiopathic dilated (IDCM) cardiomyopathy. Methods. The data of 144 patients transplanted from February 1998 to January 2011 were analyzed. 38 patients with ischemic ICM and 86 patients with IDCM were compared. Results. Recipient age, preoperative creatinine, recipient body mass index, intraoperative cross-clamp time, donor male sex ratio, recipient male sex ratio, hyperlipidemia ratio, and previous nitrate use were significantly higher and left ventricular end systolic diameter significantly lower in patients with ICM. Major causes of death after heart transplantation were infections (31.9%), right ventricle failure (14.8%), and sudden cardiac death (14.8%). Causes of death were not different between the groups. Overall mortality in the entire population was 37.9% (47/124), and it was not different between the groups (39.5% vs 37.2%; P =.48). Early mortality (<30 days) rate was 11.2% (14/124), late mortality rate was 26.6% (33/124), and no statistically significant difference was observed between the groups. Survival analysis showed that ICM patients were not associated with worse survival compared with IDCM (71.1% vs 81.1% after 1 year, 68.1% vs 73.0% at 2 years, and 54.2% vs 62.3% at 5 years; log rank = 0.57). Multivariate analysis showed that the only predictor of mortality was preoperative urea level and that heart failure etiology was not a predictor of this end point. Conclusions. Patients with ICM had similar survival and mortality rate compared with IDCM.Öğe Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters(Oxford Univ Press, 2009) Karapolat, H. K.; Demir, E. D.; Bozkaya, Y. T. B. Turan; Eyigor, S. E.; Nalbantgil, S. N.; Durmaz, B. D.; Zoghi, M.Öğe Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters(Oxford Univ Press, 2009) Karapolat, H. K.; Demir, E. D.; Bozkaya, Y. T. B. Turan; Eyigor, S. E.; Nalbantgil, S. N.; Durmaz, B. D.; Zoghi, M.Öğe Comparison of hospital-supervised exercise versus home-based exercise in patients after orthotopic heart transplantation: Effects on functional capacity, quality of life, and psychological symptoms(Elsevier Science Inc, 2007) Karapolat, H.; Eyigor, S.; Zoghi, M.; Yagdi, T.; Nalbangil, S.; Durmaz, B.In heart transplant patients it is common to observe a reduced exercise capacity and diminished quality of life. The objective of this study was to compare the effectiveness of a hospital-based exercise program versus that of a home-based exercise program on the functional capacity, quality of life, and psychological symptoms among heart transplant patients. Methods. Thirty-eight heart transplant patients were randomly placed into two groups: a hospital-based exercise program (group 1, n = 15) or a home-based exercise program (group 2, n = 13). All patients performed flexibility, stretching, aerobic, strengthening, breathing, and relaxation exercise programs for 8 weeks. We performed estimates of functional capacity (maximal oxygen consumption-pVO2), quality of life (Short Form-36-SF36), and psychological symptoms (Beck Depression Inventory-BDI, the State-Trait Anxiety Inventory-STAI). Results. In group 1, significant increases were observed in pVO2 and all SF36 subgroups, with the exception of vitality and social function subgroups (P <.05). Significant increases were not observed on the BDI or STAI (P >.05). Group 2 failed to show significant improvements in any variable, with the exception of the score on the bodily pain subgroup of the SF36 (P >.05). Conclusion. Based on our clinical results, we recommend a well-organized exercise program performed in a rehabilitation unit to improve postoperative exercise capacity and quality of life among heart transplant patients.Öğe Comparison of outcome in systolic heart failure patients using ivabradine, digoxin or neither of them: a real life study(Wiley, 2017) Ural, D.; Mutluer, F. O.; Kaya, H.; Beton, O.; Cavusoglu, Y.; Temizhan, A.; Guvenc, T. S.; Gungor, H.; Ege, M. Refiker; Zoghi, M.; Karauzum, K.; Altay, H.; Yilmaz, M. B.Öğe Demographic and clinical characteristics of atrial fibrillation patients suffering from an ACS without prior revascularization history(Oxford Univ Press, 2019) Coner, A.; Saracoglu, E.; Akdeniz, A.; Ozkan, H.; Tuluce, K.; Gul, M.; Zoghi, M.[No abstract available]Öğe Does Pretransplantation Etiology Have Any Effect on Exercise Results in Heart Transplant Patients?(Elsevier Science Inc, 2010) Karapolat, H.; Yagdi, T.; Zoghi, M.; Eyigor, S.; Engin, C.; Nalbantgil, S.; Durmaz, B.; Ozbaran, M.Objective. The objective of this study was to analyze the effect of pre-transplantation etiology and post-transplantation exercise on pulmonary function tests, functional capacities, psychological symptoms and quality of life among heart transplant patients. Methods. An eight-week exercise program was applied to 35 heart transplant patients with histories of ischemic heart failure (HF; n = 20) or dilated HF (n = 15). All patients were evaluated before and after exercise in terms of breathing function tests, functional capacity (FVC; maximal oxygen consumption, pVO2), psychological symptoms (Beck Depression Scale (BDS), Spielberger's State-Trait Anxiety Inventory (STAI)) and quality of life (Short Form 36, SF-36). Results. At the end of the exercise compared to the pre-exercise period significant improvements were observed in all FVC%, FeV1%, FeV1/FVC%, pVO2, SF 36 scores reflecting physical function, physical role, pain, general health, vitality, social function, and emotional role (P < 0.05) among heart transplant patients who were operated due to ischemic or dilated heart failure. In contrast, no significant improvement was observed in the BDS and STAI scales (P > 0.05). There was no significant etiology-related difference between the groups in terms of the evaluated parameters (P > 0.05). Conclusion. We demonstrated improvements in function tests, functional capacity and quality of life for both ischemic and dilated heart transplant patients following a supervised exercise program. We concluded that the positive effect achieved by exercise was not related to pre-transplantation etiology. Whatever the preoperative etiology, a regular exercise program is recommended for heart transplant patients in the rehabilitation unit.Öğe The Effect of Cardiac Rehabilitation on Functional Capacity, Psychological Symptoms and Quality of Life in Patients with a Left Ventricular Assist Device(Elsevier Science Inc, 2016) Cinar, E.; Karapolat, H.; Capaci, K.; Engin, C.; Yagdi, T.; Ozbaran, M.; Nalbantgil, S.; Zoghi, M.Öğe Effect of levosimendan on left atrial functions in patients with ischemic heart failure(Oxford Univ Press, 2007) Duygu, H.; Ozerkan, F.; Zoghi, M.; Nalbantgil, S.; Akilli, A.; Akin, M.Öğe The effect of levosimendan on left ventricular systolic and diastolic function and systolic pulmonary artery pressure in patients taking carvedilol(Elsevier Science Bv, 2007) Duygu, H.; Zoghi, M.; Nalbantgil, S.; Ozerkan, F.; Erturk, U.; Onder, R.; Akilli, A.; Akin, M.Öğe Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure(Wiley, 2008) Duygu, H.; Ozerkan, F.; Zoghi, M.; Nalbantgil, S.; Yildiz, A.; Akilli, A.; Akin, M.; Nazli, C.; Ergene, O.Objectives: Levosimendan is a novel positive inotropic calcium sensitiser agent used in acute left heart failure. In this study, the effect of levosimendan on the right ventricular systolic and diastolic functions was evaluated by tissue Doppler comparing them with dobutamine in patients with ischaemic heart failure. Methods: Patients having an acute decompensated heart failure with ischaemic cardiomyopathy and left ventricular ejection fraction < 40% were included in the study. Before and 24-h after treatment, peak systolic (Sa), peak early (Ea), peak late (Aa) diastolic annular velocities and Ea/Aa ratio from tricuspid lateral annulus by tissue Doppler and systolic pulmonary artery pressure (SPAP) were measured. Results: Sa, Ea and the Ea/Aa ratio were significantly increased in the levosimendan group whereas SPAP was significantly reduced. In the dobutamine group, no significant differences were observed in the Sa, Ea, Aa and Ea/Aa ratio in spite of a significant reduction in SPAP. Decrease in SPAP was greater in the levosimendan group (p = 0.002). Conclusion: Levosimendan improves right ventricular systolic and diastolic functions.
- «
- 1 (current)
- 2
- 3
- »